US firm Akerman Senterfitt has taken steps to create its first-ever firm president, nominating its chief operating shareholder to the role.
M&A partner Robert Zinn will be Akerman's inaugural president, which is akin to a managing partner at a UK firm, as first revealed by The Lawyer (23 April).
Zinn will be responsible for the day-to-day running of the firm and will report to chairman Tom Cardwell.
The 500-lawyer Florida firm, which also has offices in New York and Washington DC, is structured as a corporation rather than as a partnership, and as such refers to its senior staff as shareholders.
Akerman's clients include Arriva Pharmaceuticals and Bank of America. It was Florida's second-largest firm in 2006 by revenue. Turnover topped $210m (£104.81m) at the end of 2005, the most recent records available.